Imai; Toshiyasu
Patent Applications and Registrations
Patent applications and USPTO patent grants for Imai; Toshiyasu.The latest application filed is for "medicine for diabetic peripheral neuropathy".
- Imai; Toshiyasu - Tokyo JP
- IMAI; Toshiyasu - Misato-shi Saitama
- Imai; Toshiyasu - Saitama JP
- Imai; Toshiyasu - Misato N/A JP
- Imai; Toshiyasu - Saitama
- Imai; Toshiyasu - Chiba JP
| Patent | Date |
|---|---|
| P2X4 receptor antagonist Grant 11,434,207 - Ushioda , et al. September 6, 2 | 2022-09-06 |
| Medicine For Diabetic Peripheral Neuropathy App 20210205326 - IMAI; Toshiyasu | 2021-07-08 |
| Medicament For Treatment Of Multiple Sclerosis App 20210121478 - IMAI; Toshiyasu ; et al. | 2021-04-29 |
| Medicament For Treating Cough App 20210000840 - IMAI; Toshiyasu ; et al. | 2021-01-07 |
| P2x4 Receptor Antagonist App 20200223806 - USHIODA; Masatoshi ; et al. | 2020-07-16 |
| P2X4 receptor antagonist Grant 10,633,349 - Ushioda , et al. | 2020-04-28 |
| P2X4 receptor antagonist Grant 10,472,333 - Sakuma , et al. Nov | 2019-11-12 |
| Prophylactic Or Therapeutic Agent For Neuropathic Pain Associated With Guillain-barre Syndrome App 20190046539 - IMAI; Toshiyasu ; et al. | 2019-02-14 |
| P2X4 receptor antagonist Grant 10,150,744 - Sakuma , et al. Dec | 2018-12-11 |
| P2x4 Receptor Antagonist App 20180319752 - SAKUMA; Shogo ; et al. | 2018-11-08 |
| P2x4 Receptor Antagonist App 20180201587 - USHIODA; Masatoshi ; et al. | 2018-07-19 |
| P2X4 receptor antagonist Grant 9,969,700 - Ushioda , et al. May 15, 2 | 2018-05-15 |
| P2X4 receptor antagonist Grant 9,873,683 - Sakuma , et al. January 23, 2 | 2018-01-23 |
| P2x4 Receptor Antagonist App 20170081294 - SAKUMA; Shogo ; et al. | 2017-03-23 |
| Prophylactic Or Therapeutic Agent For Neuropathic Pain Associated With Guillain-barre Syndrome App 20170065608 - IMAI; Toshiyasu ; et al. | 2017-03-09 |
| P2x4 Receptor Antagonist App 20160280667 - USHIODA; Masatoshi ; et al. | 2016-09-29 |
| P2x4 Receptor Antagonist App 20160244434 - SAKUMA; Shogo ; et al. | 2016-08-25 |
| P2X4 receptor antagonist Grant 9,382,236 - Ushioda , et al. July 5, 2 | 2016-07-05 |
| P2X.sub.4 receptor antagonist Grant 8,962,613 - Sakuma , et al. February 24, 2 | 2015-02-24 |
| P2x4 Receptor Antagonist App 20140357858 - Ushioda; Masatoshi ; et al. | 2014-12-04 |
| Diazepinedione derivative Grant 8,778,933 - Sakuma , et al. July 15, 2 | 2014-07-15 |
| Prophylactic Or Therapeutic Agent For Neuropathic Pain Associated With Guillain-barre Syndrome App 20140163013 - Imai; Toshiyasu ; et al. | 2014-06-12 |
| P2X.sub.4 receptor antagonist Grant 8,680,110 - Ushioda , et al. March 25, 2 | 2014-03-25 |
| P 2.times.4 receptor antagonist Grant 8,673,915 - Ushioda , et al. March 18, 2 | 2014-03-18 |
| Diazepinedione Derivative App 20130281441 - Sakuma; Shogo ; et al. | 2013-10-24 |
| P2x4 Receptor Antagonist App 20130184459 - Ushioda; Masatoshi ; et al. | 2013-07-18 |
| P 2 X 4 Receptor Antagonist App 20130178625 - Ushioda; Masatoshi ; et al. | 2013-07-11 |
| P2x4 Receptor Antagonist App 20130172550 - Sakuma; Shogo ; et al. | 2013-07-04 |
| Diazepinedione derivative Grant 8,470,814 - Sakuma , et al. June 25, 2 | 2013-06-25 |
| P2x4 Receptor Antagonist App 20120116073 - SAKUMA; Shogo ; et al. | 2012-05-10 |
| Diazepinedione Derivative App 20110319610 - Sakuma; Shogo ; et al. | 2011-12-29 |
| P2x4 Receptor Antagonist App 20110092703 - Sakuma; Shogo ; et al. | 2011-04-21 |
| P2x4 Receptor Antagonist App 20100256123 - Sakuma; Shogo ; et al. | 2010-10-07 |
| N-substituted N-(4-piperidinyl) Amide Derivative App 20090030041 - Takahashi; Toshihiro ; et al. | 2009-01-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 